T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Canadian Natural Resources
CNQ
|
$764M |
| 2 |
Martin Marietta Materials
MLM
|
$558M |
| 3 |
Thermo Fisher Scientific
TMO
|
$479M |
| 4 |
Lam Research
LRCX
|
$464M |
| 5 |
argenx
ARGX
|
$367M |
Top Sells
| 1 |
Ingersoll Rand
IR
|
$1.25B |
| 2 |
Xcel Energy
XEL
|
$889M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$858M |
| 4 |
KKR & Co
KKR
|
$625M |
| 5 |
NVIDIA
NVDA
|
$618M |
Sector Composition
| 1 | Technology | 23.04% |
| 2 | Healthcare | 19.81% |
| 3 | Industrials | 12.92% |
| 4 | Consumer Discretionary | 11.63% |
| 5 | Financials | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Coastal Financial
CCB
$1.66B
| $33.8M | 0.02% |
870,281
+12,322
| +1% | +$479K |
|
452
EyePoint Pharmaceuticals
EYPT
$966M
| $33.2M | 0.02% |
1,604,763
+46,088
| +3% | +$953K |
|
453
Merus
MRUS
$5.1B
| $32.8M | 0.02% |
+729,015
| New | +$32.8M |
|
454
Visteon
VC
$3.41B
| $32.1M | 0.02% |
273,210
-19,595
| -7% | -$2.3M |
|
455
Gibraltar Industries
ROCK
$1.82B
| $31.9M | 0.02% |
396,288
-8,680
| -2% | -$699K |
|
456
AGCO
AGCO
$8.28B
| $31.7M | 0.02% |
+257,605
| New | +$31.7M |
|
457
Pacific Biosciences
PACB
$381M
| $31.5M | 0.02% |
8,397,820
+644,039
| +8% | +$2.42M |
|
|
MODN
458
DELISTED
MODEL N, INC.
MODN
| $31.3M | 0.02% |
1,098,849
-1,893
| -0.2% | -$53.9K |
|
459
CG Oncology
CGON
$2.52B
| $31.1M | 0.02% |
+708,711
| New | +$31.1M |
|
460
P10
PX
$1.32B
| $30.9M | 0.02% |
3,671,665
-1,819,709
| -33% | -$15.3M |
|
461
Williams-Sonoma
WSM
$24.7B
| $30.7M | 0.02% |
+193,524
| New | +$30.7M |
|
462
Hamilton Lane
HLNE
$6.41B
| $30.4M | 0.02% |
+269,540
| New | +$30.4M |
|
463
Knowles
KN
$1.85B
| $30.3M | 0.02% |
1,880,052
-83,605
| -4% | -$1.35M |
|
464
James River Group
JRVR
$249M
| $30M | 0.02% |
3,228,201
+187,217
| +6% | +$1.74M |
|
465
JFrog
FROG
$5.84B
| $29.8M | 0.02% |
673,229
+98,109
| +17% | +$4.34M |
|
466
Texas Roadhouse
TXRH
$11.2B
| $29.5M | 0.02% |
190,818
+27,290
| +17% | +$4.22M |
|
467
Agree Realty
ADC
$8.08B
| $29.4M | 0.02% |
514,194
+305,025
| +146% | +$17.4M |
|
468
John Marshall Bancorp
JMSB
$285M
| $29M | 0.02% |
1,619,249
+59,035
| +4% | +$1.06M |
|
469
Artesian Resources
ARTNA
$343M
| $28.8M | 0.02% |
775,432
+2,048
| +0.3% | +$76K |
|
|
AAT
470
American Assets Trust
AAT
$1.28B
| $28.7M | 0.02% |
+1,310,959
| New | +$28.7M |
|
471
Boot Barn
BOOT
$5.58B
| $28.5M | 0.02% |
+299,925
| New | +$28.5M |
|
472
Endava
DAVA
$553M
| $28.3M | 0.02% |
744,492
+263,105
| +55% | +$10M |
|
473
Akero Therapeutics
AKRO
$3.58B
| $27.8M | 0.02% |
+1,102,049
| New | +$27.8M |
|
474
Opendoor
OPEN
$4.89B
| $27.2M | 0.02% |
8,966,406
+5,827,260
| +186% | +$17.7M |
|
475
Agios Pharmaceuticals
AGIO
$2.09B
| $27.2M | 0.02% |
928,596
-1,310
| -0.1% | -$38.3K |
|